201 BROOKLINE AVENUE, BOSTON, MA
Tango Therapeutics Enters Underwriting Agreement for $182.5 Million Offering
Investor Presentation
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Financial Results and Provides Business Highlights
News, Articles of Incorporation
Reports First Quarter 2025 Financial Results and Provides Business Highlights
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
Q2
Q1
FY 2023
Q3
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Definitive Revised Proxy Statement